Microbix Biosystems Inc. shares surged by 3.23% in the latest trading session, signaling renewed investor interest.
Microbix Biosystems Inc. (MBX.TO) saw its stock price close at CA$0.32 after a 3.23% increase in the last trading day. This rise comes amid expectations of growth and strategic developments in the biotechnology sector.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Microbix Biosystems Inc.
MBX.TO
MBX.TO
Microbix Biosystems Inc.
WealthAwesomeMarket cap
$44.00M
52W high
$0.34
52W low
$0.21
1W change
+3.33%
Beta
0.57
Analyst Price Targets
Based on analyst covering MBX
Wall Street analysts forecast MBX stock price to rise 29.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.40
+29.0% Upside
Current Price
C$0.31
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MBX's historical volatility
30-Day Vol
45.1%
Annualized
90-Day Vol
55.5%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.37
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$0.33 | C$0.28 โ C$0.38 |
| 60 trading days | C$0.35 | C$0.28 โ C$0.44 |
| 90 trading days | C$0.37 | C$0.28 โ C$0.49 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Keep an eye on Microbix's upcoming financial results and industry engagements, as these could offer valuable insights into its growth and performance.
Microbix Biosystems Inc. Gains 3.23% in One Day
Microbix has a market cap of CA$44 million, positioning it as a smaller player in the biotechnology landscape.
Bull case
The recent increase in Microbix's stock price suggests that investors are optimistic about the company's operational advancements and potential revenue growth. This optimism follows the announcement of Q1 2026 results, which showed a 13% increase in revenues.
Bear case
Despite the recent gains, investors should be cautious. The company is still reporting a net loss, and any downturns in revenue or operational setbacks could negatively affect stock performance.
Recent Performance Overview
Microbix Biosystems Inc. has shown resilience with a 3.23% increase in its stock price during the last trading session. This uptick is significant given the company's recent announcements and efforts to improve its product offerings. Investors seem to be responding positively to the potential for revenue growth indicated by the recent quarterly results.
Looking Ahead: Upcoming Financial Results
With Q2 fiscal 2026 results set to be released on May 14, 2026, investors are eagerly awaiting insights into Microbix's financial health. The previous quarter's results showed a 13% revenue increase, which could create a positive outlook for future performance. Stakeholders should watch these developments closely, as they may impact stock performance in the coming weeks.
Industry Engagements and Strategic Moves
Microbix has been actively engaging with industry experts and enhancing its product lines, as seen in its recent podcast series and participation in conferences. These initiatives are key for building brand credibility and expanding market reach, which could further boost investor confidence and stock performance.
Advertisement
